Related Experiment Video
Updated: May 27, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
[Current treatment options in acute myeloid leukemia]
M Heuser1, R F Schlenk, A Ganser
1Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Carl-Neuberg Strasse 1, Hannover, Germany. heuser.michael@mh-hannover.de
Der Internist
|November 11, 2011
Summary
Genetic aberrations are key for classifying acute myeloid leukemia (AML) and predicting treatment response. Rapid genetic profiling is essential for selecting the best targeted therapies for AML patients.
Area of Science:
- Hematology
- Oncology
- Genetics
Context:
- Acute myeloid leukemia (AML) classification relies on genetic aberrations per the World Health Organization (WHO) guidelines.
- These genetic changes significantly influence patient prognosis, including response to chemotherapy and survival rates.
Purpose:
- To highlight the critical role of genetic aberrations in AML diagnosis and treatment selection.
- To emphasize the need for prompt genetic profiling in AML management.
Summary:
- Genetic aberrations are fundamental to the World Health Organization (WHO) classification of acute myeloid leukemia (AML).
- These molecular and cytogenetic alterations are crucial predictors of treatment efficacy, relapse-free survival, and overall survival in AML patients.
- Understanding the pathogenetic mechanisms of these genetic changes enables the development of targeted therapies.
Impact:
- Facilitates personalized medicine approaches in AML by guiding treatment selection based on individual genetic profiles.
- Accelerates the diagnostic process, enabling timely initiation of appropriate therapies for acute myeloid leukemia.
- Improves patient outcomes through the strategic application of targeted treatment strategies informed by genetic assessment.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...